James F. Parslow
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James F. Parslow
James F. Parslow is recorded as CEO at Xenetic Biosciences, Inc. (XBIO). Xenetic Biosciences, Inc. reported in an 8-K filed June 21, 2024 that James F. Parslow was appointed Interim Chief Executive Officer, effective May 16, 2024. Xenetic Biosciences, Inc. reported in an 8-K filed May 22, 2024 that James F. Parslow was appointed Interim Chief Executive Officer, effective May 16, 2024.
“As previously disclosed, on May 16, 2024, the Board of Directors of Xenetic Biosciences, Inc. (the “Company”) appointed James F. Parslow, the Company’s Chief Financial Officer, to the position of Interim Chief Executive Officer.”
“On May 16, 2024, the Board of Directors (the "Board") of Xenetic Biosciences, Inc. (the "Company") appointed James F. Parslow, the Company's Chief Financial Officer, to the position of Interim Chief Executive Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-05-16–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Xenetic Biosciences, Inc.
Other people whose current roles at this company are on record from its filings.
- James Parslow CEO, CFO
- Dr. Alexey Vinogradov Board Member
- Dr. Dmitry Genkin Board Member
- Dr. Grigory Borisenko Board Member
- Dr. Roger Kornberg Board Member
- Mr. Firdaus Jal Dastoor Board Member
- Mr. Moshe Mizrahy Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.